通过制剂提高孕酮的口服生物利用度。 - Suppr | 超能文献

Increasing oral bioavailability of progesterone by formulation.

作者信息

Kincl F A, Ciaccio L A, Benagiano G

出版信息

J Steroid Biochem. 1978 Jan;9(1):83-4. doi: 10.1016/0022-4731(78)90106-1.

DOI:10.1016/0022-4731(78)90106-1

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Increasing oral bioavailability of progesterone by formulation.通过制剂提高孕酮的口服生物利用度。

J Steroid Biochem. 1978 Jan;9(1):83-4. doi: 10.1016/0022-4731(78)90106-1.

2

Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats.使用动态体外脂肪分解模型来合理设计难溶性药物的口服制剂：与体内数据的相关性以及与大鼠肠细胞内过程的关系。

Pharm Res. 2006 Sep;23(9):2165-74. doi: 10.1007/s11095-006-9054-x. Epub 2006 Aug 11.

3

Pharmaceutical and clinical development of a novel progesterone formulation.一种新型孕酮制剂的药物研发与临床研究

Acta Obstet Gynecol Scand. 2015 Nov;94 Suppl 161:28-37. doi: 10.1111/aogs.12765.

4

Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.使用聚合物纳米颗粒系统提高非诺贝特的口服生物利用度：理化特性及体内研究

Int J Nanomedicine. 2015 Mar 5;10:1819-30. doi: 10.2147/IJN.S78895. eCollection 2015.

5

Oral administration of micronized progesterone: a review and more experience.微粒化孕酮的口服给药：综述及更多经验

Pharmacotherapy. 1996 May-Jun;16(3):453-7.

6

Pharmacokinetics of progesterone administered by the oral and parenteral routes.口服和肠胃外途径给药的孕酮的药代动力学。

J Reprod Med. 1999 Feb;44(2 Suppl):141-7.

7

Sustained-release hormonal preparations XV: release of progesterone from cholesterol pellets in vivo.长效激素制剂十五：胆固醇微丸中孕酮的体内释放

J Pharm Sci. 1977 Apr;66(4):490-3. doi: 10.1002/jps.2600660408.

8

Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.含新型自纳米乳化制剂的软胶囊中，无论是否进食，环孢素A的生物利用度均稳定。

Int J Clin Pharmacol Ther. 2006 May;44(5):233-9. doi: 10.5414/cpp44233.

9

Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride.含明胶微粒的自微乳化制剂设计用于提高度他雄胺的口服生物利用度

Drug Des Devel Ther. 2015 Jun 23;9:3231-8. doi: 10.2147/DDDT.S86458. eCollection 2015.

10

Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.明胶涂层混合脂质纳米粒口服 delivery 两性霉素 B。

Mol Pharm. 2012 Sep 4;9(9):2542-53. doi: 10.1021/mp300320d. Epub 2012 Aug 14.

引用本文的文献

1

Solubility Improvement of Progesterone from Solid Dispersions Prepared by Solvent Evaporation and Co-milling.通过溶剂蒸发和共研磨制备的固体分散体中孕酮的溶解度提高

Polymers (Basel). 2020 Apr 7;12(4):854. doi: 10.3390/polym12040854.

2

Pharmacokinetics of progesterone in postmenopausal women: 2. Pharmacokinetics following percutaneous administration.

Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep;23(3):397-402. doi: 10.1007/BF03192300.